RO96749B1 - Vasoactive medicament - Google Patents

Vasoactive medicament

Info

Publication number
RO96749B1
RO96749B1 RO126978A RO12697887A RO96749B1 RO 96749 B1 RO96749 B1 RO 96749B1 RO 126978 A RO126978 A RO 126978A RO 12697887 A RO12697887 A RO 12697887A RO 96749 B1 RO96749 B1 RO 96749B1
Authority
RO
Romania
Prior art keywords
drug
effects
rutacil
tablets
well
Prior art date
Application number
RO126978A
Other languages
Romanian (ro)
Other versions
RO96749A2 (en
Inventor
Nicolaie Oita
Dumitru Dobrescu
Ion Neacsu
VASILE CîNDEA
Mihai Lazar
Original Assignee
Nicolaie Oita
Dumitru Dobrescu
Ion Neacsu
VASILE CîNDEA
Mihai Lazar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nicolaie Oita, Dumitru Dobrescu, Ion Neacsu, VASILE CîNDEA, Mihai Lazar filed Critical Nicolaie Oita
Priority to RO126978A priority Critical patent/RO96749B1/en
Publication of RO96749A2 publication Critical patent/RO96749A2/en
Publication of RO96749B1 publication Critical patent/RO96749B1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Inventia de fata valorifica drep principiu activ un derivat flavonoidic diacetilat (Rutacil), cu proprietati capilaroprotectoare superioare, precum si cu efecte hipocolesterolemiante, hipolipemiante, antiagregant-plachetare, antiinflamatoare si diuretice. Asocierea acidului ascorbic, a vitaminei PP sub forma de xantinol-nicotinat, a ATP si a ionilor de Mg2+, ca glutamat, potenteaza efectele Rutacilului în contextul medicamentului. Medicamentul este indicat în tratamentul tulburarilor circulatorii, atât centrale, cât si periferice, al tulburarilor circulatorii cauzate de traumatisme cranio-cerebrale sau pe fond de scleroza si diabet, precum si ca stabilizator al tensiunii. Prezentarea medicamentului sub forma de comprimate usureaza administrarea si dozarea acestuia. Fiind lipsit de toxicitate si având efecte secundare nesemnificative, medicamentul poate fi aplicat pe perioadele lungi de timp si în doze ce pot varia dupa caz, de la 3x1 pâna la 3x4 comprimate pe zi.The present invention advantageously employs a diacetylated flavonoid derivative (Rutacil) with higher capillary-protective properties, as well as with hypocolesterolemitic, hypolipidemic, antiaggregant-platelet, anti-inflammatory and diuretic effects. The combination of ascorbic acid, vitamin PP in the form of xanthinol-nicotinate, ATP and Mg2 + ions, such as glutamate, potentiates the effects of Rutacil in the context of the drug. The drug is indicated for the treatment of circulatory disorders, both central and peripheral, of circulatory disorders caused by cranio-cerebral trauma or on the basis of sclerosis and diabetes, as well as as a stabilizer of tension. Presentation of the drug in the form of tablets facilitates its administration and dosing. Being unlikely and having minor side effects, the drug can be applied over long periods of time and in doses that may vary from 3x1 to 3x4 tablets a day.

RO126978A 1987-02-11 1987-02-11 Vasoactive medicament RO96749B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RO126978A RO96749B1 (en) 1987-02-11 1987-02-11 Vasoactive medicament

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RO126978A RO96749B1 (en) 1987-02-11 1987-02-11 Vasoactive medicament

Publications (2)

Publication Number Publication Date
RO96749A2 RO96749A2 (en) 1989-04-28
RO96749B1 true RO96749B1 (en) 1989-04-29

Family

ID=20120412

Family Applications (1)

Application Number Title Priority Date Filing Date
RO126978A RO96749B1 (en) 1987-02-11 1987-02-11 Vasoactive medicament

Country Status (1)

Country Link
RO (1) RO96749B1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19538666A1 (en) * 1995-10-17 1997-04-24 Leniger Follert Elfriede Prof Medicines used to treat arterial occlusive diseases, microangiopathies and microcirculation disorders

Also Published As

Publication number Publication date
RO96749A2 (en) 1989-04-28

Similar Documents

Publication Publication Date Title
NO922940L (en) FIVE-JOINT HETEROCYCLIC COMPOUNDS, PROCEDURES FOR THEIR PREPARATION AND MEDICINES CONTAINING THEM
NO944778L (en) Des-Tyr-dynorfinanaloger
DE324227T1 (en) COMPOSITION FOR INCREASING INTRA-CELL-ATP LEVELS AND PHYSICAL PERFORMANCE LEVELS AND FOR INCREASING THE SPEED OF Wounds Healing.
CA2114014A1 (en) Advanced Drug Delivery System and Method of Treating Psychiatric, Neurological and Other Disorders with Carbamazepine
DE68910159T2 (en) Dosage form for administration in human medicine.
IT1170215B (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF STATES OF ACUTE RENAL INSUFFICIENCY
ATE240344T1 (en) NOR-PREGNANES TO INDUCE HYPOTHALAMIC EFFECTS
DE68909409T2 (en) MEDICAL DOSAGE FOR ADMINISTRATION TO FISH.
MY103741A (en) Process for producing an administration and/or dosage form for medicinal active substances by means of a printing process
KR970025615A (en) Cancer metastasis inhibitor
ITRM910002A1 (en) USE OF ACETYL L-CARNITINE IN THERAPEUTIC TREATMENT OF COMA AND PHARMACEUTICAL COMPOSITIONS USEFUL IN SUCH TREATMENT.
DE68926115D1 (en) METHOD FOR TREATING ACNE
RO96749B1 (en) Vasoactive medicament
ES8705763A1 (en) Pharmaceutical compositions containing gels.
DE69015910D1 (en) Pharmaceutical use of fatty acids.
MY130107A (en) Piperidylmethyl-substituted chroman derivatives
DK1231908T3 (en) A pharmaceutical composition comprising an NO donor compound and its use
KR880009656A (en) Treatment or prophylaxis of local periodontal disease
GB1460325A (en) Pharmaceutical composition intended for relieving pain and producing analgesia
KR940006600A (en) Use of direct inhibitors of thrombin for the manufacture of medicinal products with thrombolytic activity
DE68901656D1 (en) PHARMACEUTICAL COMPOSITION FOR REDUCING THE SIDE EFFECTS OF MEDICINAL PRODUCTS CONTAINING PLATINUM.
KR880010762A (en) Composition and Method for Treatment of peptic Ulcers
ATE55254T1 (en) REDUCING THE TOXIC EFFECTS OF ANTHRACHINONE MEDICATIONS.
SU950391A1 (en) Multiple sclerosis treatment method
ES458413A1 (en) Pharmaceutical composition